Singapore: The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate gr...
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressu...
Singapore: With the forthcoming election for the board of directors of AusBiotech for 20013-14, nominations are now open...
Singapore: The Japanese pharma major Takeda, recently announced that the company has entered into a strategic partnershi...
Singapore: A public health alert has been sounded in Sydney after a person contracted the highly infectious virus. The d...
Singapore: Uniting healthcare recently inaugurated Australia's first digital hospital in Queensland. The $96 mn hospital...
Singapore: CSL Biotherapies, a subsidiary of CSL Limited, has been awarded a contract by the US Department of Health and...
Singapore: The Korean Food and Drug Administration (KFDA) has approved Australia-based medical device firm Nanosonics' ...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Singapore: Boehringer Ingelheim has acquired investigational drug PXS4728A from Australia based Pharmaxis, to develop it...
Singapore: Australia based, Circadian Technologies, through its wholly owned subsidiary Opthea has recieved USFDA approv...
Singapore: AusBiotech and Korea Biotechnology Industry Organization (KoreaBIO) are signing a memorandum of understanding...
Singapore: In a bid to reduce the soaring cases of skin cancer in the country, many states of Australia are set to ban c...
Singapore: Australian biomedical company Allied Healthcare launched cardiovascular tissue patch, CardioCel, to surgicall...
Singapore: Peanut allergy is one of the most dreaded forms of allergies across the globe. It is recognized as some of th...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA)'s Abraxane (nanoparticle album...
Singapore: Australian vaccine development company BioDiem has been grated a key European patent for its synthetic antim...
Singapore: Prana Biotechnology has raised $6 million (A$6 million) approximately through a placement of 32,500,000 ordin...
